Novartis AG vs United Parcel Service, Inc.: Strategic Comparison
Key Differences at a Glance
| Field | Novartis AG | United Parcel Service, Inc. |
|---|---|---|
| Revenue | $54.5B | $88.7B |
| Founded | 1996 | 1907 |
| Employees | 75,267 | 460,000 |
| Market Cap | $274.1B | $98.9B |
| Headquarters | Switzerland | United States |
Quick Stats Comparison
| Metric | Novartis AG | United Parcel Service, Inc. |
|---|---|---|
| Revenue | $54.5B | $88.7B |
| Founded | 1996 | 1907 |
| Headquarters | Basel, Switzerland | Atlanta, Georgia |
| Market Cap | $274.1B | $98.9B |
| Employees | 75,267 | 460,000 |
Novartis AG Revenue vs United Parcel Service, Inc. Revenue — Year by Year
| Year | Novartis AG | United Parcel Service, Inc. | Leader |
|---|---|---|---|
| 2025 | $54.5B | $88.7B | United Parcel Service, Inc. |
| 2024 | $50.3B | $91.1B | United Parcel Service, Inc. |
| 2023 | $45.4B | $91.0B | United Parcel Service, Inc. |
Business Model Breakdown
Overview: Novartis AG vs United Parcel Service, Inc.
This in-depth comparison examines Novartis AG and United Parcel Service, Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Novartis AG on its own, evaluating United Parcel Service, Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Novartis AG and United Parcel Service, Inc. is widest.
On the headline numbers, Novartis AG reports annual revenue of $54.5B against $88.7B for United Parcel Service, Inc., while their respective market capitalizations stand at $274.1B and $98.9B. Novartis AG is headquartered in Switzerland and United Parcel Service, Inc. operates from United States, and those different home markets shape how each company competes.
Novartis AG: Novartis AG is a public company listed on NYSE under ticker NVS. Novartis makes money by discovering, developing, manufacturing, and commercializing patented medicines across cardiovascular, renal and metabolic, immunology, neuroscience, and oncology markets.
United Parcel Service, Inc.: UPS is not simply a delivery company. It is a daily density network: the more packages moving through routes, hubs, aircraft, and delivery stops, the more efficiently each incremental package can be handled.
Business Models: How Novartis AG and United Parcel Service, Inc. Make Money
Novartis AG and United Parcel Service, Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Novartis AG and United Parcel Service, Inc..
Novartis AG business model: Novartis makes money by discovering, developing, manufacturing, and commercializing patented medicines across cardiovascular, renal and metabolic, immunology, neuroscience, and oncology markets.
United Parcel Service, Inc. business model: UPS makes money from U.S. domestic package delivery, international package delivery, air and ground shipping, brokerage, contract logistics, healthcare cold chain, freight forwarding, returns, insurance, UPS Store services, and digital logistics offerings.
Competitive Advantage: Novartis AG vs United Parcel Service, Inc.
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Novartis AG stack up against those of United Parcel Service, Inc..
Novartis AG competitive advantage: Novartis's advantage is a focused patented-medicine portfolio, global commercial reach, scale in clinical development, and specialty platforms such as radioligand therapy.
United Parcel Service, Inc. competitive advantage: UPS's advantage is route density, integrated air-ground operations, trusted service quality, global customs and brokerage capability, package tracking data, enterprise customer relationships, and specialized healthcare logistics infrastructure.
Growth Strategy: Where Novartis AG and United Parcel Service, Inc. Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Novartis AG and United Parcel Service, Inc. each plan to expand from here.
Novartis AG growth strategy: Novartis AG's growth strategy centers on this advantage: Novartis's advantage is a focused patented-medicine portfolio, global commercial reach, scale in clinical development, and specialty platforms such as radioligand therapy.
United Parcel Service, Inc. growth strategy: UPS is emphasizing higher-yield parcels, SMB penetration, healthcare logistics, international package growth, automation, RFID-enabled package visibility, network reconfiguration, and disciplined capital spending.
Financial Picture: Novartis AG vs United Parcel Service, Inc.
A closer look at the financial trajectory of Novartis AG and United Parcel Service, Inc. rounds out the comparison.
Novartis AG: Novartis AG reported FY2025 revenue of $54.532B and net income of $13.967B.
United Parcel Service, Inc.: UPS reported USD 88.7 billion in 2025 revenue, USD 7.9 billion in operating profit, and 8.9% operating margin. The company delivered 5.2 billion packages and continued shifting toward higher-yielding volume, healthcare logistics, SMBs, B2B, and international opportunities.
Company-Specific SWOT Notes
Novartis AG
After Sandoz and Alcon separations, Novartis is concentrated around branded, higher-margin medicines and specialty platforms.
Large franchises can lose sales quickly when exclusivity ends or payers switch patients to generics and biosimilars.
Radioligand therapy, oncology, immunology, and cardiovascular launches can offset mature-product pressure.
Drug-price controls, reimbursement restrictions, safety findings, and clinical failures can materially affect growth.
United Parcel Service, Inc.
UPS's advantage is route density, integrated air-ground operations, trusted service quality, global customs and brokerage capability, package tracking data, enterprise customer relationships, and specialized healthcare logistics infrastructure.
UPS wins when package density, reliable service, and integrated air-ground logistics make it cheaper and safer for customers to use UPS than to stitch together alternatives.
The biggest risk is that falling low-yield volume, labor inflation, or Amazon-related shifts reduce network density faster than UPS can reprice and reconfigure operations.
UPS is emphasizing higher-yield parcels, SMB penetration, healthcare logistics, international package growth, automation, RFID-enabled package visibility, network reconfiguration, and disciplined capital spending.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | United Parcel Service, Inc. | United Parcel Service, Inc. reports the larger revenue base ($88.7B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | United Parcel Service, Inc. | Founded in 1996 vs 1907. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Novartis AG | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | United Parcel Service, Inc. | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Novartis AG | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
United Parcel Service, Inc. reports the larger revenue base ($88.7B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1996 vs 1907. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Novartis AG or United Parcel Service, Inc.?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Novartis AG vs United Parcel Service, Inc.
Is Novartis AG better than United Parcel Service, Inc.?
Verdict: Between Novartis AG and United Parcel Service, Inc., United Parcel Service, Inc. is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, United Parcel Service, Inc. comes out ahead in this Novartis AG vs United Parcel Service, Inc. comparison.
Who earns more — Novartis AG or United Parcel Service, Inc.?
United Parcel Service, Inc. earns more with $88.7B in annual revenue versus Novartis AG's $54.5B. United Parcel Service, Inc. leads on total revenue based on latest verified figures.
Which company has higher revenue — Novartis AG or United Parcel Service, Inc.?
Novartis AG reported $54.5B, while United Parcel Service, Inc. reported $88.7B. The revenue leader is United Parcel Service, Inc. based on latest verified figures.
Novartis AG revenue vs United Parcel Service, Inc. revenue — which is higher?
Novartis AG revenue: $54.5B. United Parcel Service, Inc. revenue: $54.5B. United Parcel Service, Inc. has the larger revenue base of the two companies.
Sources & References
- Novartis AG Corporate Website
- Novartis AG Annual Report 2025 - Revenue and Financial Data
- sec.gov
- novartis.com
- SEC EDGAR: United Parcel Service, Inc. Annual Filings (10-K, 8-K)
- United Parcel Service, Inc. Corporate Website
- United Parcel Service, Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- investors.ups.com
- about.ups.com